Actively Recruiting
PEGASUS - Improving Treatment for Patients With Emotionally Unstable Personality Disorder
Led by University Hospital Bispebjerg and Frederiksberg · Updated on 2026-04-28
100
Participants Needed
1
Research Sites
260 weeks
Total Duration
On this page
Sponsors
U
University Hospital Bispebjerg and Frederiksberg
Lead Sponsor
H
Hvidovre University Hospital
Collaborating Sponsor
AI-Summary
What this Trial Is About
The purpose of the PEGASUS study is to conduct a pilot trial to test the feasibility and acceptability of the PEGASUS intervention, adding a case manager and family-based interventions meetings to the existing psychiatric integrated care-models known as "Treatment Packages" in Denmark. We will conduct a randomized, assessor-blinded parallel-groups superiority clinical trial, testing the PEGASUS intervention for emotionally unstable personality disorder "EUPD", borderline type (borderline personality disorder) compared to "Treatment as Usual" before moving on to testing in a full-scale trial. Participants will be assessed at baseline and 9 month post baseline at study conclusion
CONDITIONS
Official Title
PEGASUS - Improving Treatment for Patients With Emotionally Unstable Personality Disorder
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Must be able to give an informed written consent.
- Must be newly accepted in the pre-planned BPD treatment packages.
- 18 years of age or older.
- Agreeing to involvement of one or two informal caregivers, families, or close friends ("Relatives").
- Capable of reading and understanding Danish.
You will not qualify if you...
- Patients must not have a diagnosis of F20 or meet criteria for alcohol or substance abuse or harmful use to be accepted into the BPD treatment package.
- No other exclusion criteria for patients or relatives.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Copenhagen Research Center for Mental Health - CORE
Copenhagen, Denmark, 2900
Actively Recruiting
Research Team
D
Ditte H. Rotvig, MD
CONTACT
C
Carsten Hjorthøj, Ph.d.
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here